Streetbeat News

Earnings

ALLR

Allarity Therapeutics (NASDAQ:ALLR) reported Q4 earnings with an EPS of $-0.34, missing estimates by -36.0%. Revenue remained unchanged from the previous year. Despite beating EPS estimates last quarter, this miss could impact investor sentiment.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 2:15 pm

BROS

MNKD

RIG

RIOT

SOFI

SPT

Jim Cramer discussed various stocks on CNBC's 'Mad Money Lightning Round,' highlighting Sprout Social's potential despite not making money, expressing caution about MannKind, preferring Bitcoin over Riot Platforms, criticizing Transocean's expansion, praising Dutch Bros' strategy adjustment, and maintaining belief in SoFi Technologies despite a recent convertible note offering. He recommended SLB and Halliburton over Transocean. Recent financial updates and stock movements for these companies were also mentioned.

Portfolio Pulse from Avi Kapoor

March 08, 2024 | 2:13 pm

OCUL

Ocular Therapeutix (NASDAQ:OCUL) is scheduled to release its quarterly earnings report on March 11, 2024, with analysts expecting an EPS of $-0.30. Historical data shows mixed reactions to past earnings, with the last quarter beating estimates but resulting in a 13.2% share price drop. Shares have risen 108.17% over the last year, indicating positive sentiment among long-term investors.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 2:01 pm

SILV

SilverCrest Metals (AMEX:SILV) is scheduled to release its quarterly earnings report on March 11, 2024, with analysts expecting an EPS of $0.10. The company's past performance shows a history of beating EPS estimates, which has positively impacted its share price. However, shares have declined by 6.12% over the last 52 weeks. Investors will be looking for not only an earnings beat but also positive guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 2:01 pm

AVO

Mission Produce (NASDAQ:AVO) is scheduled to release its quarterly earnings report on March 11, 2024, with analysts expecting an EPS of $-0.06. The company's past performance shows a mix of earnings beats and misses, with share price reactions varying accordingly. Shares were trading at $10.98 as of March 06, with a 2.04% increase over the last 52 weeks. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 2:01 pm

BODI

The Beachbody Company, Inc. (NYSE:BODI) is expected to report a Q4 earnings per share (EPS) of $-3.12 on March 11, 2024. Analysts and investors are looking for an earnings beat and positive guidance for the next quarter. Historically, BODI has missed EPS estimates in the past four quarters, leading to significant price drops. Shares are currently trading at $9.48, down 73.3% over the last 52 weeks, indicating a bearish outlook from long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 2:01 pm

PACK

Ranpak Holdings (NYSE:PACK) is scheduled to release its quarterly earnings report on March 11, 2024, with analysts expecting an EPS of $-0.04. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's beat leading to a 14.87% drop. Shares are currently trading at $4.45, down 4.91% over the last year. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 2:01 pm

BWMN

Bowman Consulting Group (NASDAQ:BWMN) is scheduled to release its quarterly earnings report on March 11, 2024. Analysts predict an EPS of $-0.07. The company's past performance shows a mix of earnings beats and misses, with the last quarter beating EPS estimates by $0.21, leading to a 1.4% share price increase the following day. Shares are currently trading at $34.48, up 20.14% over the last year. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 2:01 pm

EXK

Endeavour Silver (NYSE:EXK) is scheduled to release its quarterly earnings report on March 11, 2024, with an estimated EPS of $0.02. Historical data shows a mixed reaction to past earnings, with the last quarter missing estimates and resulting in a 5.37% share price drop. Over the last year, EXK shares have declined by 37.1%, indicating potential investor concern ahead of the upcoming earnings announcement.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 2:01 pm

CVGW

Calavo Growers (NASDAQ:CVGW) is scheduled to release its quarterly earnings report on March 11, 2024, with an estimated EPS of $0.17. Historical data shows mixed earnings performance, with a notable miss last quarter leading to a 6.09% share price drop. Shares have risen 26.35% over the past year, indicating positive long-term investor sentiment. The upcoming earnings guidance will be crucial for short-term stock movement.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 2:00 pm